Dr judith silverstein m d online dating for dummies
She said she believes that biology, in addition to psychology, could be a factor. there is a physiological release — after a buildup of sexual tension — which may lead to tears (or laughter) not accounted for by psychological variables,” she said.
Continue reading Everyone, it seems, has an opinion on the FDA’s approval this week of the drug Flibanserin, aka “pink Viagra,” to boost women’s sexual desire.
I believe that they want to help women who are struggling with sexual desire. She’s a marketing professional, and she’s darn good at her job.
We asked our readers: How did you decide whether to introduce the topic of adoption at your child's school?
“This is the biggest breakthrough for women’s sexual health since the pill,” Sally Greenberg, executive director of the National Consumers League, told The New York Times. Cindy Pearson, of the National Women’s Health Network, told NPR that approval of the drug “is a triumph of marketing over science” and added: “To have any chance of benefit from this drug they’re going to have to take it every day for months on end, years…We just don’t know what the long-term effects will be of changing brain chemistry in this way.” Janet Woodcock, M.
D., director of the FDA’s Center for Drug Evaluation and Research (CDER), said the approval “provides women distressed by their low sexual desire with an approved treatment option…The FDA strives to protect and advance the health of women, and we are committed to supporting the development of safe and effective treatments for female sexual dysfunction.” The drug, which will be sold under the brand name Addyi, is expected to go on sale Oct.
Past sexual abuse may play a role in some cases, but this particular study suggests it’s not the main driver.
Judy Silverstein, a psychologist and sex therapist in Needham, Massachusetts, says she’s worked with many women who have tears or sadness after sex.